KRT14 (Keratin, type I cytoskeletal 14) variants and mutations
KRT14 (also known as Keratin, type I cytoskeletal 14) is a human protein-coding gene encoding a keratin, type I cytoskeletal 14 protein. It pairs with keratin 5 to provide mechanical strength to basal epidermal keratinocytes. Dominant-negative variants are a major cause of epidermolysis bullosa simplex, while other variants can cause pigmentation disorders or ectodermal phenotypes. This analysis covers 937 KRT14 variants and mutations. Of these, 84% have computational variant effect predictions. Disease context includes epidermolysis bullosa simplex 1A, generalized severe, epidermolysis bullosa simplex 1C, localized, and Naegeli-Franceschetti-Jadassohn syndrome. Example KRT14 variants include T2A, T2P, and C4Y.
Variant analysis overview
- Gene: KRT14
- Protein: Keratin, type I cytoskeletal 14
- UniProt accession: P02533
- Organism: Homo sapiens
- Variants analyzed: 937
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 662 unspecified-consequence records; 2 stop lost; 1 stop retained variant; 100 synonymous variants; 146 missense variants; 4 in-frame deletions; 8 stop-gained variants; 9 frameshift variants; 6 splice-region variants; 1 in-frame insertions; 2 substitution
- Prediction scores: 787 variants have prediction scores (84% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: epidermolysis bullosa simplex 1A, generalized severe, epidermolysis bullosa simplex 1C, localized, Naegeli-Franceschetti-Jadassohn syndrome, epidermolysis bullosa simplex 1B, generalized intermediate, dermatopathia pigmentosa reticularis, epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal, Epidermolysis bullosa simplex, Dowling-Meara type, Generalized epidermolysis bullosa simplex, non-Dowling-Meara type, Localized epidermolysis bullosa simplex, epidermolysis bullosa simplex, KRT14-related epidermolysis bullosa simplex, hereditary disease.
Protein structure and variant hotspots
- Protein features: 1 domains; 1 post-translational modification sites.
- Structural context: 581 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KRT14 variants
Examples include T2A, T2P, C4Y, S5G, S5T, R6C, R6H, R6L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- T2A (p.Thr2Ala), ExAC rs765738033, gnomAD rs765738033, REVEL 0.17, CADD 16.60
- T2P (p.Thr2Pro), ExAC rs765738033, gnomAD rs765738033
- C4Y (p.Cys4Tyr), Ensembl rs1449926174, REVEL 0.18, CADD 20.30
- S5G (p.Ser5Gly), ExAC rs753894587, REVEL 0.29, CADD 22.00
- S5T (p.Ser5Thr), Ensembl rs2144586911
- R6C (p.Arg6Cys), ExAC rs766646368, TOPMed rs766646368, gnomAD rs766646368, REVEL 0.59, CADD 28.70
- R6H (p.Arg6His), rs760882737, ClinGen CA8562840, ClinVar RCV003553203, ExAC rs760882737, REVEL 0.37, CADD 23.80, Uncertain significance, not provided
- R6L (p.Arg6Leu), ExAC rs760882737, TOPMed rs760882737, gnomAD rs760882737, REVEL 0.47, CADD 25.00, Uncertain significance
- R6P (p.Arg6Pro), ExAC rs760882737, TOPMed rs760882737, gnomAD rs760882737, REVEL 0.50, CADD 23.90, Uncertain significance
- R6S (p.Arg6Ser), ExAC rs766646368, TOPMed rs766646368, gnomAD rs766646368, REVEL 0.39, CADD 22.80
- Q7* (p.Gln7Ter), rs267607391, ClinGen CA216885, ClinVar RCV000056699, ClinVar RCV000415603, CADD 41.00, Pathogenic
- Q7H (p.Gln7His), ExAC rs763817312, gnomAD rs763817312, REVEL 0.39, CADD 22.90
- Q7P (p.Gln7Pro), gnomAD rs1235530318, REVEL 0.54, CADD 25.50
- F8S (p.Phe8Ser), TOPMed rs1156635262, gnomAD rs1156635262, REVEL 0.13, CADD 22.40
- T9I (p.Thr9Ile), gnomAD rs1410997626, REVEL 0.28, CADD 22.80
- S10F (p.Ser10Phe), Ensembl rs868637793
- S10P (p.Ser10Pro), gnomAD rs1374827316, REVEL 0.60, CADD 27.00
- S10E (p.Ser10Glu), rs868637793, []
- M14I (p.Met14Ile), NCI-TCGA Cosmic COSV9939, REVEL 0.18, CADD 19.60, Variant assessed as somatic; moderate impact.
- M14L (p.Met14Leu), TOPMed rs1350093432, gnomAD rs1350093432, REVEL 0.24, CADD 14.80
- M14R (p.Met14Arg), gnomAD rs1166730746
- M14T (p.Met14Thr), gnomAD rs1166730746, REVEL 0.23, CADD 21.80
- M14V (p.Met14Val), TOPMed rs1350093432, gnomAD rs1350093432
- K15E (p.Lys15Glu), gnomAD rs1455415891, REVEL 0.36, CADD 26.20
- K15R (p.Lys15Arg), gnomAD rs1318809672, REVEL 0.25, CADD 22.70
- G16D (p.Gly16Asp), NCI-TCGA Cosmic COSV9939, REVEL 0.49, CADD 23.80, Variant assessed as somatic; moderate impact.
- S17F (p.Ser17Phe), TOPMed rs1457403673, gnomAD rs1457403673, REVEL 0.22, CADD 22.10
- C18* (p.Cys18Ter), rs60831116, ClinGen CA124159, ClinVar RCV000015731, ClinVar RCV000056744, CADD 32.00, Pathogenic
- C18G (p.Cys18Gly), rs1159749209, ClinGen CA399483830, ClinVar RCV003669819, gnomAD rs1159749209, REVEL 0.15, CADD 22.60, Uncertain significance, not provided
- C18S (p.Cys18Ser), gnomAD rs1159749209, REVEL 0.16, CADD 18.20, Uncertain significance
- G19S (p.Gly19Ser), 1000Genomes rs769745467, ExAC rs769745467, TOPMed rs769745467, gnomAD rs769745467, REVEL 0.23, CADD 17.80
- I20S (p.Ile20Ser), gnomAD rs1189537125, REVEL 0.39, CADD 20.60
- G21E (p.Gly21Glu), gnomAD rs1215846581, REVEL 0.26, CADD 22.20
- G21R (p.Gly21Arg), TOPMed rs1253837899, gnomAD rs1253837899, REVEL 0.50, CADD 22.20
- G23C (p.Gly23Cys), 1000Genomes rs777522790, ExAC rs777522790, TOPMed rs777522790, gnomAD rs777522790, REVEL 0.61, CADD 23.50
- G23D (p.Gly23Asp), NCI-TCGA Cosmic COSV5142, REVEL 0.59, CADD 23.40, Variant assessed as somatic; moderate impact.
- G23S (p.Gly23Ser), 1000Genomes rs777522790, ExAC rs777522790, TOPMed rs777522790, gnomAD rs777522790, REVEL 0.36, CADD 21.60
- I24F (p.Ile24Phe), TOPMed rs1597800161
- I24T (p.Ile24Thr), gnomAD rs1299888635
- G25E (p.Gly25Glu), TOPMed rs1327472230, gnomAD rs1327472230, REVEL 0.15, CADD 15.50
- G25R (p.Gly25Arg), rs556526711, ClinGen CA8562829, ClinVar RCV003821324, 1000Genomes rs556526711, REVEL 0.25, CADD 16.80, Uncertain significance, not provided
- G26A (p.Gly26Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G27A (p.Gly27Ala), rs1159632697, ClinGen CA399483640, ClinVar RCV004412196, ClinVar RCV006483952, REVEL 0.24, CADD 17.30, Uncertain significance, not provided; Inborn genetic diseases
- G27S (p.Gly27Ser), ExAC rs779340321, gnomAD rs779340321, REVEL 0.31, CADD 17.40
- S28F (p.Ser28Phe), 1000Genomes rs538124790, ExAC rs538124790, TOPMed rs538124790, gnomAD rs538124790
- S28P (p.Ser28Pro), Ensembl rs200941154, REVEL 0.54, CADD 25.00
- S28Y (p.Ser28Tyr), 1000Genomes rs538124790, ExAC rs538124790, TOPMed rs538124790, gnomAD rs538124790, REVEL 0.56, CADD 23.80
- S29G (p.Ser29Gly), ExAC rs753987047, REVEL 0.27, CADD 19.50
- R30C (p.Arg30Cys), rs201069984, ClinGen CA216988, ClinVar RCV000056756, ClinVar RCV000714552, REVEL 0.34, CADD 24.00, Conflicting interpretations, not provided; Epidermolysis bullosa simplex 1D, generalized, intermediate or sev
- R30H (p.Arg30His), ExAC rs756137651, TOPMed rs756137651, gnomAD rs756137651, REVEL 0.29, CADD 23.70, Uncertain significance, not provided
- R30L (p.Arg30Leu), rs756137651, ClinGen CA399483601, ClinVar RCV002730685, ExAC rs756137651, REVEL 0.46, CADD 23.70, Uncertain significance, not provided
- R30S (p.Arg30Ser), 1000Genomes rs201069984, ESP rs201069984, ExAC rs201069984, TOPMed rs201069984, REVEL 0.47, CADD 23.50, Benign
- I31F (p.Ile31Phe), ExAC rs750673779, gnomAD rs750673779, REVEL 0.13, CADD 17.40
- V34I (p.Val34Ile), rs762702328, ClinGen CA8562819, NCI-TCGA Cosmic COSV5142, ClinVar RCV002922571, REVEL 0.04, CADD 8.79, Uncertain significance, Inborn genetic diseases; not provided
- L35M (p.Leu35Met), NCI-TCGA Cosmic COSV9939, REVEL 0.13, CADD 14.70, Variant assessed as somatic; moderate impact.
- L35V (p.Leu35Val), 1000Genomes rs548262562, TOPMed rs548262562, gnomAD rs548262562, REVEL 0.11, CADD 10.90
- A36T (p.Ala36Thr), gnomAD rs1254737268, REVEL 0.12, CADD 8.74
- G37* (p.Gly37Ter), TOPMed rs1312208815, gnomAD rs1312208815, CADD 35.00
- G37R (p.Gly37Arg), rs1312208815, NCI-TCGA Cosmic COSV5142, TOPMed rs1312208815, gnomAD rs1312208815, REVEL 0.23, CADD 15.90, Variant assessed as somatic; moderate impact.
- G38E (p.Gly38Glu), ExAC rs765150501, TOPMed rs765150501, gnomAD rs765150501, REVEL 0.56, CADD 23.60
- G38W (p.Gly38Trp), Ensembl rs1907548075
- S39A (p.Ser39Ala), Ensembl rs1597800087
- S39F (p.Ser39Phe), TOPMed rs11551750, gnomAD rs11551750, REVEL 0.43, CADD 23.00
- S39Y (p.Ser39Tyr), NCI-TCGA TCGA novel, REVEL 0.47, CADD 22.90, Variant assessed as somatic; moderate impact.
- C40F (p.Cys40Phe), TOPMed rs1354476154, gnomAD rs1354476154, REVEL 0.19, CADD 15.70
- R41C (p.Arg41Cys), 1000Genomes rs536753971, ExAC rs536753971, TOPMed rs536753971, gnomAD rs536753971, REVEL 0.37, CADD 23.30
- R41G (p.Arg41Gly), 1000Genomes rs536753971, ExAC rs536753971, TOPMed rs536753971, gnomAD rs536753971, REVEL 0.38, CADD 22.50
- R41H (p.Arg41His), rs566001198, ClinGen CA8562813, ClinVar RCV003088814, ClinVar RCV003095715, REVEL 0.31, CADD 22.40, Uncertain significance, Inborn genetic diseases; not provided
- R41L (p.Arg41Leu), 1000Genomes rs566001198, ExAC rs566001198, TOPMed rs566001198, gnomAD rs566001198, REVEL 0.42, CADD 18.50, Uncertain significance
- R41P (p.Arg41Pro), 1000Genomes rs566001198, ExAC rs566001198, TOPMed rs566001198, gnomAD rs566001198, REVEL 0.56, CADD 22.60, Uncertain significance
- R41S (p.Arg41Ser), 1000Genomes rs536753971, ExAC rs536753971, TOPMed rs536753971, gnomAD rs536753971, REVEL 0.41, CADD 22.30
- A42S (p.Ala42Ser), TOPMed rs1250998048, gnomAD rs1250998048, REVEL 0.30, CADD 22.20
- A42T (p.Ala42Thr), rs1250998048, TOPMed rs1250998048, gnomAD rs1250998048, REVEL 0.39, CADD 22.90, Variant assessed as somatic; moderate impact.
- A42V (p.Ala42Val), Ensembl rs1907547021, REVEL 0.42, CADD 22.90
- P43L (p.Pro43Leu), gnomAD rs1302148281, REVEL 0.38, CADD 22.70
- S44N (p.Ser44Asn), rs773041960, ExAC rs773041960, gnomAD rs773041960, REVEL 0.27, CADD 17.70, Variant assessed as somatic; moderate impact.
- T45I (p.Thr45Ile), rs201931536, ClinGen CA8562810, ClinVar RCV002885835, 1000Genomes rs201931536, REVEL 0.13, CADD 14.60, Likely benign, not provided
- Y46D (p.Tyr46Asp), Ensembl rs753338461
- G47E (p.Gly47Glu), gnomAD rs1194215362, REVEL 0.53, CADD 22.60
- G47R (p.Gly47Arg), rs374429058, ClinGen CA8562808, ClinVar RCV002951865, ClinVar RCV005399199, REVEL 0.45, CADD 22.60, Uncertain significance, Inborn genetic diseases; Epidermolysis bullosa simplex 1A, generalized severe; D
- G48A (p.Gly48Ala), NCI-TCGA TCGA novel, REVEL 0.35, CADD 15.60, Variant assessed as somatic; high impact.
- G48D (p.Gly48Asp), 1000Genomes rs550076306, gnomAD rs550076306, REVEL 0.35, CADD 23.00
- G49D (p.Gly49Asp), gnomAD rs1486286930, REVEL 0.43, CADD 15.60
- G49S (p.Gly49Ser), ExAC rs768837237, TOPMed rs768837237, gnomAD rs768837237, REVEL 0.25, CADD 6.66, Uncertain significance, not provided
- L50P (p.Leu50Pro), gnomAD rs1202404380
- V52A (p.Val52Ala), gnomAD rs1270390371, REVEL 0.32, CADD 16.30
- V52F (p.Val52Phe), TOPMed rs1340895845, gnomAD rs1340895845, REVEL 0.43, CADD 18.50
- V52I (p.Val52Ile), TOPMed rs1340895845, gnomAD rs1340895845, REVEL 0.23, CADD 18.10
- S54F (p.Ser54Phe), gnomAD rs11551751, REVEL 0.31, CADD 20.60
- S54P (p.Ser54Pro), ExAC rs756225120, TOPMed rs756225120, gnomAD rs756225120, REVEL 0.40, CADD 9.85, Uncertain significance, not provided
- S55P (p.Ser55Pro), rs2144586557, ClinGen CA399483236, ClinVar RCV002042420, Ensembl rs2144586557, AlphaMissense 0.25, MetaLR 0.42, Uncertain significance, not provided
- R56C (p.Arg56Cys), rs117484558, ClinGen CA8562802, ClinVar RCV000963160, ClinVar RCV002489369, REVEL 0.38, CADD 22.50, Benign/Likely benign, Epidermolysis bullosa simplex 1A, generalized severe; Dermatopathia pigmentosa r
- R56H (p.Arg56His), rs1427865521, NCI-TCGA Cosmic COSV5142, gnomAD rs1427865521, REVEL 0.35, CADD 21.00, Variant assessed as somatic; moderate impact.
- R56S (p.Arg56Ser), 1000Genomes rs117484558, ESP rs117484558, ExAC rs117484558, TOPMed rs117484558, REVEL 0.42, CADD 19.80, Benign
- S59F (p.Ser59Phe), ExAC rs751661237, TOPMed rs751661237, gnomAD rs751661237, REVEL 0.39, CADD 21.00
- G60A (p.Gly60Ala), TOPMed rs1907543300
- G60E (p.Gly60Glu), TOPMed rs1907543300, REVEL 0.37, CADD 16.20
- G60R (p.Gly60Arg), TOPMed rs1367015717, gnomAD rs1367015717, REVEL 0.58, CADD 16.70
- G60W (p.Gly60Trp), TOPMed rs1367015717, gnomAD rs1367015717, REVEL 0.46, CADD 23.40
- G61* (p.Gly61Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G61A (p.Gly61Ala), Ensembl rs1907543032, REVEL 0.34, CADD 10.00
- G61E (p.Gly61Glu), rs1907543032, ClinGen CA399483134, NCI-TCGA Cosmic COSV5142, NCI-TCGA Cosmic COSV9906, REVEL 0.41, CADD 13.50, Uncertain significance, KRT14-related disorder
- G61R (p.Gly61Arg), ExAC rs753861629
- A62D (p.Ala62Asp), ExAC rs760311515, REVEL 0.33, CADD 6.71
- A62V (p.Ala62Val), ExAC rs760311515
- C63=, rs1555572096, ClinVar RCV000056696, Benign
- C63F (p.Cys63Phe), 1000Genomes rs6503640, ExAC rs6503640, TOPMed rs6503640, gnomAD rs6503640, REVEL 0.22, CADD 0.00, Benign
- C63S (p.Cys63Ser), 1000Genomes rs6503640, ExAC rs6503640, TOPMed rs6503640, gnomAD rs6503640, REVEL 0.20, CADD 0.00, Benign
- C63W (p.Cys63Trp), 1000Genomes rs11551758, ExAC rs11551758, TOPMed rs11551758, gnomAD rs11551758, Benign
- C63Y (p.Cys63Tyr), rs6503640, ClinGen CA8562793, ClinVar RCV002191745, ClinVar RCV002496123, REVEL 0.24, CADD 0.00, Benign, Epidermolysis bullosa simplex 1A, generalized severe; Dermatopathia pigmentosa r
- G64R (p.Gly64Arg), gnomAD rs1273137363, REVEL 0.59, CADD 19.60
- G64V (p.Gly64Val), gnomAD rs1197117964, REVEL 0.61, CADD 15.40
- L65M (p.Leu65Met), 1000Genomes rs3826551, ESP rs3826551, ExAC rs3826551, TOPMed rs3826551, Benign
- L65V (p.Leu65Val), 1000Genomes rs3826551, ESP rs3826551, ExAC rs3826551, TOPMed rs3826551, REVEL 0.24, CADD 2.01, Benign
- G66R (p.Gly66Arg), ExAC rs749619996, gnomAD rs749619996, REVEL 0.58, CADD 22.10
- G66W (p.Gly66Trp), ExAC rs749619996, gnomAD rs749619996, REVEL 0.58, CADD 24.20
- G67D (p.Gly67Asp), ExAC rs780585472, gnomAD rs780585472, REVEL 0.49, CADD 21.50
- G67R (p.Gly67Arg), Ensembl rs1907541592
- G68S (p.Gly68Ser), rs142137272, ClinGen CA8562786, ClinVar RCV000253938, ClinVar RCV000894279, REVEL 0.28, CADD 13.60, Benign/Likely benign, not provided; not specified
- Y69* (p.Tyr69Ter), ExAC rs757222057, gnomAD rs757222057
- Y69C (p.Tyr69Cys), ESP rs374199640, ExAC rs374199640, TOPMed rs374199640, gnomAD rs374199640, REVEL 0.50, CADD 24.20
- Y69F (p.Tyr69Phe), NCI-TCGA Cosmic COSV5142, Variant assessed as somatic; moderate impact.
- G70C (p.Gly70Cys), gnomAD rs1393300239
- G71D (p.Gly71Asp), ExAC rs753666745, TOPMed rs753666745, gnomAD rs753666745
- G71S (p.Gly71Ser), rs556361680, ClinGen CA8562780, ClinVar RCV001969812, 1000Genomes rs556361680, REVEL 0.46, CADD 20.20, Uncertain significance, not provided
- G71V (p.Gly71Val), ExAC rs753666745, TOPMed rs753666745, gnomAD rs753666745, REVEL 0.57, CADD 19.70
- G72D (p.Gly72Asp), ExAC rs750261536, TOPMed rs750261536, gnomAD rs750261536, REVEL 0.29, CADD 21.50
- G72S (p.Gly72Ser), Ensembl rs61729636, REVEL 0.15, CADD 12.40
- G72V (p.Gly72Val), ExAC rs750261536, TOPMed rs750261536, gnomAD rs750261536, REVEL 0.31, CADD 17.30
- F73Y (p.Phe73Tyr), NCI-TCGA Cosmic COSV5142, Variant assessed as somatic; moderate impact.
- S74I (p.Ser74Ile), NCI-TCGA Cosmic COSV9939, Variant assessed as somatic; moderate impact.
- S74N (p.Ser74Asn), ExAC rs761188204, gnomAD rs761188204, REVEL 0.17, CADD 19.60
- S75G (p.Ser75Gly), ExAC rs763711752, gnomAD rs763711752, REVEL 0.12, CADD 18.60
- S76N (p.Ser76Asn), gnomAD rs1266187782
- S78G (p.Ser78Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S78T (p.Ser78Thr), gnomAD rs1336609835, REVEL 0.29, CADD 14.20
- S79G (p.Ser79Gly), gnomAD rs1907538490
- S79N (p.Ser79Asn), ExAC rs775825212, gnomAD rs775825212, REVEL 0.13, CADD 3.12
- G81C (p.Gly81Cys), Ensembl rs1907538115, REVEL 0.57, CADD 15.20
- S82R (p.Ser82Arg), TOPMed rs1907537948, REVEL 0.35, CADD 0.01
- G83A (p.Gly83Ala), ExAC rs746395789, TOPMed rs746395789, gnomAD rs746395789, REVEL 0.33, CADD 8.41
- G83S (p.Gly83Ser), ExAC rs770075340, gnomAD rs770075340, REVEL 0.40, CADD 10.20
- G85A (p.Gly85Ala), TOPMed rs1907537451, REVEL 0.26, CADD 15.70
- G85R (p.Gly85Arg), TOPMed rs1280526971, gnomAD rs1280526971, REVEL 0.35, CADD 15.30
- G85V (p.Gly85Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G85W (p.Gly85Trp), TOPMed rs1280526971, gnomAD rs1280526971, REVEL 0.34, CADD 20.10
- G86A (p.Gly86Ala), TOPMed rs1463244515, gnomAD rs1463244515, REVEL 0.26, CADD 8.65
- G86E (p.Gly86Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G89A (p.Gly89Ala), ExAC rs778192358, TOPMed rs778192358, gnomAD rs778192358, REVEL 0.43, CADD 19.70
- G89D (p.Gly89Asp), ExAC rs778192358, TOPMed rs778192358, gnomAD rs778192358, REVEL 0.51, CADD 22.90
- G89S (p.Gly89Ser), gnomAD rs1325417504, REVEL 0.38, CADD 19.70, Uncertain significance, Inborn genetic diseases
- G90C (p.Gly90Cys), Ensembl rs374413464
- G91D (p.Gly91Asp), rs1450806388, TOPMed rs1450806388, gnomAD rs1450806388, REVEL 0.51, CADD 22.00, Variant assessed as somatic; moderate impact.
- G93D (p.Gly93Asp), Ensembl rs1597799907, REVEL 0.61, CADD 22.60
- A94G (p.Ala94Gly), ExAC rs749163953, gnomAD rs749163953, REVEL 0.26, CADD 0.12
- A94T (p.Ala94Thr), rs3826550, ClinGen CA216890, ClinVar RCV000056702, ClinVar RCV000248897, REVEL 0.32, CADD 12.30, Benign, not specified; not provided
- A94V (p.Ala94Val), ExAC rs749163953, gnomAD rs749163953, REVEL 0.27, CADD 0.10
- L96F (p.Leu96Phe), ExAC rs750404298, gnomAD rs750404298, REVEL 0.30, CADD 0.00
- G97A (p.Gly97Ala), TOPMed rs1907535014
- G98A (p.Gly98Ala), gnomAD rs1476741932, REVEL 0.37, CADD 3.47
- G98D (p.Gly98Asp), gnomAD rs1476741932, REVEL 0.44, CADD 10.40
- G99S (p.Gly99Ser), gnomAD rs1376594848, REVEL 0.38, CADD 15.50
- F100L (p.Phe100Leu), ExAC rs751018324, gnomAD rs751018324, REVEL 0.27, CADD 0.00
- G101A (p.Gly101Ala), 1000Genomes rs536296269, ExAC rs536296269, gnomAD rs536296269, REVEL 0.38, CADD 10.90
- G102A (p.Gly102Ala), ExAC rs775062151, gnomAD rs775062151, REVEL 0.36, CADD 1.18
- G102R (p.Gly102Arg), TOPMed rs1907533972, REVEL 0.42, CADD 9.74
- G103D (p.Gly103Asp), Ensembl rs1907533683
- G103S (p.Gly103Ser), ExAC rs765604315, gnomAD rs765604315
- A105G (p.Ala105Gly), Ensembl rs1555572045, REVEL 0.19, CADD 2.53
- A105P (p.Ala105Pro), ExAC rs771322821, TOPMed rs771322821, gnomAD rs771322821
- G106A (p.Gly106Ala), Ensembl rs2144586141, REVEL 0.25, CADD 1.66
- G106S (p.Gly106Ser), Ensembl rs1907532993, REVEL 0.29, CADD 11.00
- D108E (p.Asp108Glu), rs773422606, ClinGen CA8562742, ClinVar RCV003870931, ExAC rs773422606, REVEL 0.32, CADD 1.54, Uncertain significance, not provided
- G109A (p.Gly109Ala), ExAC rs772213277, TOPMed rs772213277, gnomAD rs772213277, REVEL 0.39, CADD 14.00, Uncertain significance, Inborn genetic diseases
- L110F (p.Leu110Phe), ExAC rs748396111, TOPMed rs748396111, gnomAD rs748396111, Uncertain significance
- L110V (p.Leu110Val), rs748396111, ClinGen CA8562740, ClinVar RCV003870930, ExAC rs748396111, REVEL 0.46, CADD 22.00, Uncertain significance, not provided
- L111P (p.Leu111Pro), TOPMed rs1326842738
- S114R (p.Ser114Arg), ExAC rs769668914, gnomAD rs769668914, REVEL 0.55, CADD 21.20
- K116* (p.Lys116Ter), rs60338701, ClinGen CA216895, ClinVar RCV000056705, ClinVar RCV001352789, AlphaMissense 0.99, MetaLR 0.93, Pathogenic, in EBS1C
- K116E (p.Lys116Glu), rs60338701, ClinGen CA216893, ClinVar RCV000056704, Ensembl rs60338701, AlphaMissense 0.99, MetaLR 0.93, not provided
Public KRT14 analysis runs
- KRT14 analysis run — KRT14 (937 variants) — completed 2026-08-21